SI3086781T1 - Farmacevtski sestavek zaviralca dpp-iv v kombinaciji z metforminom - Google Patents
Farmacevtski sestavek zaviralca dpp-iv v kombinaciji z metforminomInfo
- Publication number
- SI3086781T1 SI3086781T1 SI201432049T SI201432049T SI3086781T1 SI 3086781 T1 SI3086781 T1 SI 3086781T1 SI 201432049 T SI201432049 T SI 201432049T SI 201432049 T SI201432049 T SI 201432049T SI 3086781 T1 SI3086781 T1 SI 3086781T1
- Authority
- SI
- Slovenia
- Prior art keywords
- metformin
- dpp
- inhibitor
- combination
- pharmaceutical composition
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 title 1
- 229960003105 metformin Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI201300444 | 2013-12-23 | ||
SI201400275 | 2014-07-31 | ||
EP14824001.3A EP3086781B1 (en) | 2013-12-23 | 2014-12-23 | Pharmaceutical composition of dpp-iv inhibitor in combination with metformin |
PCT/EP2014/079199 WO2015097234A1 (en) | 2013-12-23 | 2014-12-23 | Pharmaceutical composition of dpp-iv inhibitor in combination with metformin |
Publications (1)
Publication Number | Publication Date |
---|---|
SI3086781T1 true SI3086781T1 (sl) | 2023-12-29 |
Family
ID=52282728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201432049T SI3086781T1 (sl) | 2013-12-23 | 2014-12-23 | Farmacevtski sestavek zaviralca dpp-iv v kombinaciji z metforminom |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3086781B1 (sl) |
EA (1) | EA032126B1 (sl) |
SI (1) | SI3086781T1 (sl) |
WO (1) | WO2015097234A1 (sl) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105769796B (zh) * | 2016-05-04 | 2019-06-04 | 杭州百诚医药科技股份有限公司 | 一种含有维格列汀和盐酸二甲双胍的药物制剂及其制备方法 |
JP2017222592A (ja) * | 2016-06-14 | 2017-12-21 | エルメッド エーザイ株式会社 | ビルダグリプチン含有医薬組成物、医薬組成物におけるビルダグリプチンの安定化方法、及びビルダグリプチンの安定化剤 |
WO2018050892A1 (en) * | 2016-09-16 | 2018-03-22 | Galenicum Health S.L. | Vildagliptin pharmaceutical compositions |
CN107007579B (zh) * | 2017-05-27 | 2020-04-28 | 南京优科制药有限公司 | 含有盐酸二甲双胍与维格列汀复方制剂的制备方法 |
EP3793529A1 (en) | 2018-05-18 | 2021-03-24 | Galenicum Health S.L.U. | Stable pharmaceutical compositions of dpp-iv inhibitors in combination with metformin in the form of immediate release tablets |
KR102647472B1 (ko) * | 2018-07-31 | 2024-03-14 | 한미약품 주식회사 | 디펩티딜 펩티다아제-4 억제제 및 메트포르민을 포함하는 경구용 고형 복합제제 및 이의 제조방법 |
GR1009644B (el) * | 2018-09-25 | 2019-11-12 | Φαρματεν Α.Β.Ε.Ε. | Φαρμακευτικο σκευασμα που περιλαμβανει βιλνταγλιπτινη και μετφορμινη και μεθοδος για την παρασκευη αυτου |
JP7299984B2 (ja) * | 2019-08-01 | 2023-06-28 | 沢井製薬株式会社 | ビルダグリプチン含有乾式造粒末、ビルダグリプチン含有錠剤及びその製造方法 |
TR202009946A2 (tr) * | 2020-06-25 | 2022-01-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Vi̇ldagli̇pti̇n ve metformi̇n hci i̇çeren bi̇r stabi̇l kombi̇nasyon |
CN114306267A (zh) * | 2020-09-30 | 2022-04-12 | 深圳翰宇药业股份有限公司 | 一种西格列汀二甲双胍片制剂及其制备方法 |
TR202022144A1 (tr) * | 2020-12-29 | 2022-07-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Alogli̇pti̇n i̇çeren farmasöti̇k kompozi̇syonlar |
JP7437039B2 (ja) * | 2021-03-12 | 2024-02-22 | 日新製薬株式会社 | 錠剤 |
WO2022211762A1 (en) * | 2021-03-29 | 2022-10-06 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | The film coated tablet of vildagliptin and metformin hydrochloride |
CN114886862B (zh) * | 2022-05-17 | 2024-02-02 | 北京悦康科创医药科技股份有限公司 | 一种复方降糖药物制剂及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JOP20180109A1 (ar) * | 2005-09-29 | 2019-01-30 | Novartis Ag | تركيبة جديدة |
SI2459531T1 (sl) * | 2009-07-31 | 2020-02-28 | Krka, D.D., Novo Mesto | Granulat, ki obsega vildagliptin, in postopek njegove priprave |
-
2014
- 2014-12-23 WO PCT/EP2014/079199 patent/WO2015097234A1/en active Application Filing
- 2014-12-23 EA EA201691322A patent/EA032126B1/ru not_active IP Right Cessation
- 2014-12-23 EP EP14824001.3A patent/EP3086781B1/en active Active
- 2014-12-23 SI SI201432049T patent/SI3086781T1/sl unknown
Also Published As
Publication number | Publication date |
---|---|
EP3086781B1 (en) | 2023-09-13 |
EA201691322A1 (ru) | 2016-10-31 |
WO2015097234A1 (en) | 2015-07-02 |
EP3086781A1 (en) | 2016-11-02 |
EA032126B1 (ru) | 2019-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI3086781T1 (sl) | Farmacevtski sestavek zaviralca dpp-iv v kombinaciji z metforminom | |
IL268623B (en) | History of piperidinyl indole and their use as complement factor b inhibitors | |
HK1223975A1 (zh) | 含納米氣泡的組合物及其用途 | |
IL244995B (en) | A pharmaceutical composition containing a pcsk9 inhibitor in the treatment of hyperlipidemia | |
PL3030262T3 (pl) | Złożona kompozycja farmaceutyczna | |
GB201317286D0 (en) | Composition and Use | |
GB2522178B (en) | Multilayer composition | |
GB201321693D0 (en) | Composition and uses thereof | |
IL240553B (en) | il-1ß inhibitory compounds and use thereof | |
SG11201601477VA (en) | Pharmaceutical composition | |
GB201301979D0 (en) | New composition and use thereof | |
EP3022205A4 (en) | NOVEL PHOSPHODIESTERASE INHIBITORS AND USES THEREOF | |
EP2939668A4 (en) | PDK4 INHIBITOR AND USE THEREOF | |
HK1220143A1 (zh) | 藥物組合物 | |
IL271456B (en) | Pharmaceutical composition comprising pcsk9 inhibitor for use in treating hyperlipidemia | |
HK1217950A1 (zh) | 新型 抑制劑 | |
LT2883541T (lt) | Kompozicija, apimanti hialurono rūgštį, skirta vietiniam naudojimui | |
SG11201507720PA (en) | Anti-tumoral composition comprising a pi3kbeta-selective inhibitor and a pi3kalpha-selective inhibitor | |
GB201322467D0 (en) | Composition and use | |
GB201309603D0 (en) | Novel compounds and their use as kinase inhibitors | |
GB201305741D0 (en) | Novel compounds and their use as kinase inhibitors | |
GB201304675D0 (en) | Novel compositions having use in therapy | |
GB201313605D0 (en) | Novel compounds and their use | |
GB201314623D0 (en) | Novel mucinase for use in therapy or prophylaxis | |
GB201301022D0 (en) | Composition and uses thereof |